Skip to main content
SpringerLink
Log in

Efficacy of nifekalant hydrochloride on the treatment of life-threatening ventricular tachyarrhythmias during reperfusion for acute myocardial infarction

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

An Erratum to this article was published on 01 January 2002

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nakaya H, Tohse N, Takeda Y, Kanno M. Effect of MS-551, a newclass III antiarrhythmic drug, on action potential andmembrane currents in rabbit ventricular myocyte. Br J Pharmacol 1993; 109: 157-163.

    PubMed  Google Scholar 

  2. Chen J, Komori S, Li B, Tamura K, Hashimoto K. IKindependent class III actions on MS-551 compared with sematilide and dofetilide during reperfusion in anesthetized rats. Br J Pharmacol 1996; 119: 937-942.

    PubMed  Google Scholar 

  3. Friedrichs GS, Chi L, Black SC, Manley PJ, Lucchesi BR. Antiarrhythmic agent, MS-551, protects against pinacidil + hypoxia-induced ventricular fibrillation in Langendorffperfused rabbit isolated heart. J Cardiovasc Pharmacol 1994; 23: 120-126.

    PubMed  Google Scholar 

  4. Kamiya J, Ishii M, Katakami T. Antiarrhythmic effect of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia. Japan J Pharmacol 1992; 58: 107-115.

    Google Scholar 

  5. Hashimoto K, Ishii M, Kamiya J. Cellular electrophysiological effects of MS-551, a new class III antiarrhythmic agent, in various cardiac tissues: Comparison with d-sotalol. Eur J Pharmacol 1990; 183: 1164.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Science and Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan

    Tomomi Koizumi, Nobuyuki Komiyama & Issei Komuro

  2. Division of Cardiology, Cardiovascular Center, Toranomon Hospital, Toranomon, Tokyo, Japan

    Takashi Tanigawa, Takashi Iwase, Sugao Ishiwata, Shin-ichirou Nishiyama, Shigemoto Nakanishi & Shin-ichi Momomura

Authors
  1. Tomomi Koizumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuyuki Komiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Issei Komuro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Tanigawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takashi Iwase
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sugao Ishiwata
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shin-ichirou Nishiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shigemoto Nakanishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shin-ichi Momomura
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1023/A:1017473331466

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koizumi, T., Komiyama, N., Komuro, I. et al. Efficacy of nifekalant hydrochloride on the treatment of life-threatening ventricular tachyarrhythmias during reperfusion for acute myocardial infarction. Cardiovasc Drugs Ther 15, 363–365 (2001). https://doi.org/10.1023/A:1012723101831

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012723101831

Search

Navigation